Mechanisms of physiological and pathological cardiac hypertrophy

M Nakamura, J Sadoshima - Nature Reviews Cardiology, 2018 - nature.com
Cardiomyocytes exit the cell cycle and become terminally differentiated soon after birth.
Therefore, in the adult heart, instead of an increase in cardiomyocyte number, individual …

Neurohormonal activation in heart failure with reduced ejection fraction

J Hartupee, DL Mann - Nature Reviews Cardiology, 2017 - nature.com
Heart failure with reduced ejection fraction (HFrEF) develops when cardiac output falls as a
result of cardiac injury. The most well-recognized of the compensatory homeostatic …

Cardiac resident macrophages prevent fibrosis and stimulate angiogenesis

XS Revelo, P Parthiban, C Chen, F Barrow… - Circulation …, 2021 - Am Heart Assoc
Rationale: The initial hypertrophy response to cardiac pressure overload is considered
compensatory, but with sustained stress, it eventually leads to heart failure. Recently, a role …

The N6-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy

LE Dorn, L Lasman, J Chen, X Xu, TJ Hund… - Circulation, 2019 - Am Heart Assoc
Background: N 6-Methyladenosine (m6A) methylation is the most prevalent internal
posttranscriptional modification on mammalian mRNA. The role of m6A mRNA methylation …

Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets

YK Tham, BC Bernardo, JYY Ooi, KL Weeks… - Archives of …, 2015 - Springer
The onset of heart failure is typically preceded by cardiac hypertrophy, a response of the
heart to increased workload, a cardiac insult such as a heart attack or genetic mutation …

Cardiovascular toxicity of nicotine: implications for electronic cigarette use

NL Benowitz, AD Burbank - Trends in cardiovascular medicine, 2016 - Elsevier
The cardiovascular safety of nicotine is an important question in the current debate on the
benefits vs. risks of electronic cigarettes and related public health policy. Nicotine exerts …

mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification

R Kumari, P Ranjan, ZG Suleiman… - Cardiovascular …, 2022 - academic.oup.com
Among several known RNA modifications, N6‐methyladenosine (m6A) is the most studied
RNA epitranscriptomic modification and controls multiple cellular functions during …

Insulin signaling and heart failure

C Riehle, ED Abel - Circulation research, 2016 - Am Heart Assoc
Heart failure is associated with generalized insulin resistance. Moreover, insulin-resistant
states such as type 2 diabetes mellitus and obesity increases the risk of heart failure even …

Stroke–heart syndrome: recent advances and challenges

JF Scheitz, LA Sposato, J Schulz‐Menger… - Journal of the …, 2022 - Am Heart Assoc
After ischemic stroke, there is a significant burden of cardiovascular complications, both in
the acute and chronic phase. Severe adverse cardiac events occur in 10% to 20% of …

Single-cell sequencing of the healthy and diseased heart reveals cytoskeleton-associated protein 4 as a new modulator of fibroblasts activation

MM Gladka, B Molenaar, H De Ruiter, S Van Der Elst… - Circulation, 2018 - Am Heart Assoc
Background: Genome-wide transcriptome analysis has greatly advanced our understanding
of the regulatory networks underlying basic cardiac biology and mechanisms driving …